# Efficacy and Safety Study of Tunodafil Hydrochloride Tablets in Erectile Dysfunction

> **NCT07692867** · PHASE3 · COMPLETED · sponsor: **Yangtze River Pharmaceutical Group Co., Ltd.** · enrollment: 780 (actual)

## Conditions studied

- Erectile Dysfunction

## Interventions

- **DRUG:** Tunodafil Hydrochloride Tablets 50mg
- **DRUG:** Placebo
- **DRUG:** Tunodafil Hydrochloride Tablets 100mg

## Key facts

- **NCT ID:** NCT07692867
- **Lead sponsor:** Yangtze River Pharmaceutical Group Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-01
- **Primary completion:** 2021-11-23
- **Final completion:** 2022-01-25
- **Target enrollment:** 780 (ACTUAL)
- **Last updated:** 2026-07-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07692867

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07692867, "Efficacy and Safety Study of Tunodafil Hydrochloride Tablets in Erectile Dysfunction". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07692867. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*